• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

a year ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Outset PR Develops Strategies for Effective AI Content

chest

Outset PR develops content strategies that cater to both human readers and AI models, ensuring clarity and usability.

user avatarRajesh Kumar

Outset PR Carves Out Niche in Data-Driven Crypto PR

chest

Outset PR has carved out a specific niche in the crowded crypto PR landscape by defining and owning the term 'data-driven crypto PR'.

user avatarGustavo Mendoza

Long-Term Bitcoin Holders Begin Selling Amid Market Changes

chest

Long-term Bitcoin holders have sold approximately 143,000 BTC in the past 30 days, indicating a shift in market sentiment.

user avatarKaterina Papadopoulou

Ripple Positioned for Growth as Regulatory Challenges Ease

chest

Ripple has seen a significant price increase and is positioned for further growth as regulatory challenges ease.

user avatarMiguel Rodriguez

DOJ's Crypto Enforcement Memo Under Fire

chest

The April 2025 memo from the DOJ has been criticized for its approach to cryptocurrency enforcement, coinciding with the disbanding of the National Cryptocurrency Enforcement Team.

user avatarLuis Flores

Solana's Meme Coin BP Surges Dramatically

chest

Solana's on-chain Meme Coin BP has seen a dramatic surge in market capitalization, reaching $149 million, a 608% increase in 24 hours, driven by social media activity.

user avatarMaria Gutierrez

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.